Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Borderline Personality Disorder: early-phase trial registry
6 of 17 indexed Borderline Personality Disorder trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,004 of 28,707 conditions by registered trial count.
17 US clinical trials · 6 currently recruiting · #1,004 of 28,707 conditions by registered trial count
Borderline Personality Disorder: 17 US clinical trials tracked, 6 recruiting.
Borderline Personality Disorder is the subject of 17 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Yale University, running 3 of these trials.
Enrollment posture brief
Registry condition borderline-personality-disorder
OPEN 6 | RECR 35% | LATE 0 | EARLY 5 | RANK #1004 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Arrhythmia (35% recruiting · 17 trials)
Borderline Personality Disorder lists 6 open slots (35% of 17 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Borderline Personality Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Borderline Personality Disorder is recruiting below its size-band peers.
6 of 17 indexed trials (35.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Borderline Personality Disorder research.
Yale University accounts for 3 of 17 trials (17.6%). 13 distinct sponsors appear on at least one study for this condition label.
-
Most Borderline Personality Disorder trials plan to enrol fewer than 100 people.
Median target enrolment is 61 among the 17 trials that report a genuine target (sentinel values excluded). 12 of those (70.6%) plan for fewer than 100 participants.
-
Borderline Personality Disorder research is mostly interventional.
16 interventional and 1 observational studies make up this index (94.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
17 total, page 1 of 1
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
Massachusetts General Hospital
NCT04296604
Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder
Yale University
NCT06446765
Cognitive Reappraisal Training for Borderline Personality (BPD)
Icahn School of Medicine at Mount Sinai
NCT06772831
Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics
Massachusetts General Hospital
NCT04130958
Treatment of Borderline Personality Disorder With rTMS
University of California, Los Angeles
NCT07197502
MDMA in Borderline Personality Disorder
Yale University
NCT06683014
Neurofeedback for Borderline Personality Disorder
Kymberly Young
NCT05398627
Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS
Stanford University
NCT04870255
Personality Change Study for Borderline Personality Disorder
Shannon E. Sauer-Zavala
NCT06005129
PILOT Phase: BPD Study
University of California, Los Angeles
NCT07223619
Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)
Otsuka Pharmaceutical Development & Commercialization
NCT04186403
Treatment of Suicidal Women With Borderline Personality Disorder
University of Washington
NCT00183651
Preschooler Emotion Regulation in the Context of Maternal Borderline Personality Disorder
University of Oregon
NCT03060902
An 18-Month Psychotherapy of Borderline Personality Disorder
Weill Medical College of Cornell University
NCT03329677
fMRI in Impulsivity
Boehringer Ingelheim
NCT02755181
Creativity Group for Borderline Personality Disorder
State University of New York - Upstate Medical University
NCT01343550
Measuring the Impact of Real Time fMRI Neurofeedback in Borderline Personality Disorder
Yale University
NCT04306341
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Borderline Personality Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Borderline Personality Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Borderline Personality Disorder page
17 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Borderline Personality Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Yale University sponsors the most Borderline Personality Disorder trials on record, review their full trial history before evaluating a specific study. See Yale University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Borderline Personality Disorder condition card totals 17 registered trials; most-linked intervention Transcranial Magnetic Stimulation (TMS); top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.